Your browser doesn't support javascript.
loading
Downregulation of type III interferons in patients with severe COVID-19.
Fukuda, Yosuke; Homma, Tetsuya; Inoue, Hideki; Onitsuka, Chisato; Ikeda, Hitoshi; Goto, Yuiko; Sato, Yoko; Kimura, Tomoyuki; Hirai, Kuniaki; Ohta, Shin; Yamamoto, Mayumi; Kusumoto, Sojiro; Suzuki, Shintaro; Tanaka, Akihiko; Sagara, Hironori.
Afiliação
  • Fukuda Y; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Homma T; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Inoue H; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Onitsuka C; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Ikeda H; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Goto Y; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Sato Y; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kimura T; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Hirai K; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Ohta S; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Yamamoto M; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kusumoto S; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Suzuki S; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Tanaka A; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Sagara H; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
J Med Virol ; 93(7): 4559-4563, 2021 07.
Article em En | MEDLINE | ID: mdl-33811680
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferons / Quimiocinas / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferons / Quimiocinas / SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão